ArticleOncology research2026
Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer.
Weixiang Song, Yanbo Zhang, Xubo Shen, Qin Yu, Yujin Liu, Yongchun Yu, Rui Chen
Abstract read
In one paragraphArticle in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Weixiang SongDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yanbo ZhangDepartment of Oncology, Shuguang Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xubo ShenDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Qin YuDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yujin LiuDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yongchun YuInstitute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Rui ChenDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AcrylamidesAniline CompoundsCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmExosomesLung NeoplasmsMicroRNAsPTEN PhosphohydrolaseRNA, Long NoncodingAnimalsApoptosisCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansIndolesAcrylamidesAniline CompoundsH19 long non-coding RNAIndolesMicroRNAsosimertinibPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanPyrimidinesRNA, Competitive EndogenousRNA, Long NoncodingexosomeslncRNA H19non-small cell lung cancerosimertinibphosphatase and tensin homolog (PTEN)
Identifiers
PMID42220422
PMCPMC13220100
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390